Literature DB >> 8540848

Retinal venous sheathing and the blood-retinal barrier in multiple sclerosis.

M K Birch1, S Barbosa, L D Blumhardt, C O'Brien, S P Harding.   

Abstract

OBJECTIVE: To assess the temporal relations among retinal appearance, disruption of the blood-retinal barrier, clinical subgroup, disease course, and disruption of the blood-brain barrier in multiple sclerosis.
DESIGN: A 6-month prospective study involving monthly clinical ocular examinations, color fundus photography, fundus fluorescein angiograms, and magnetic resonance brain scans with gadolinium-diethylenetriamine-pentaacetic acid (Gd-DPTA) enhancement.
SETTING: University-based ophthalmology and neurology departments. PATIENTS: Twenty-three patients with relapsing-remitting, primary-progressive, or secondary-progressive multiple sclerosis.
RESULTS: Retinal venous sheathing was seen in six patients. The appearances observed included focal venous sheathing, diffuse venous sheathing, sheathing centered on sites of arteriovenous crossover, and focal perivenous hemorrhage. Arteriolar sheathing was also observed in one patient. Venous leakage on fundus fluorescein angiogram was detected in three patients, all of whom also had sheathing. The following three patterns of disruption of the blood-retinal barrier were seen on fundus fluorescein angiogram: focal leakage, extensive leakage, and very late wall staining. In one patient, the leakage was transitory. No correlations were observed between ophthalmologic features and multiple sclerosis clinical subgroup, disease course, or the number of new (Gd-DTPA-enhancing) lesions on magnetic resonance imaging.
CONCLUSIONS: Disruption of the blood-retinal barrier, like the more frequent disruption of the blood-brain barrier seen on magnetic resonance imaging, is often unrelated to clinical neurologic relapses and occurs with apparently similar frequency in different patients independent of clinical disease course.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8540848     DOI: 10.1001/archopht.1996.01100130032005

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  11 in total

1.  Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies.

Authors:  Farzin Forooghian; Melanie Sproule; Carol Westall; Lynn Gordon; Guy Jirawuthiworavong; Kaori Shimazaki; Paul O'Connor
Journal:  Doc Ophthalmol       Date:  2006-09-14       Impact factor: 2.379

Review 2.  Ophthalmic eponyms from the Mayo Clinic.

Authors:  G B Bartley
Journal:  Doc Ophthalmol       Date:  1997       Impact factor: 2.379

3.  Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures.

Authors:  Olwen C Murphy; Ohemaa Kwakyi; Mustafa Iftikhar; Sidra Zafar; Jeffrey Lambe; Nicole Pellegrini; Elias S Sotirchos; Natalia Gonzalez-Caldito; Esther Ogbuokiri; Angeliki Filippatou; Hunter Risher; Norah Cowley; Sydney Feldman; Nicholas Fioravante; Elliot M Frohman; Teresa C Frohman; Laura J Balcer; Jerry L Prince; Roomasa Channa; Peter A Calabresi; Shiv Saidha
Journal:  Mult Scler       Date:  2019-05-16       Impact factor: 6.312

4.  Endovascular correction of cerebrovenous anomalies in multiple sclerosis: a retrospective review of an uncontrolled case series.

Authors:  Michael D Dake; Nicholas Dantzker; William L Bennett; John P Cooke
Journal:  Vasc Med       Date:  2012-04-10       Impact factor: 3.239

5.  Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration.

Authors:  Ari J Green; Stephen McQuaid; Stephen L Hauser; Ingrid V Allen; Roy Lyness
Journal:  Brain       Date:  2010-04-21       Impact factor: 13.501

6.  Differential diagnosis of retinal vasculitis.

Authors:  Ahmed M Abu El-Asrar; Carl P Herbort; Khalid F Tabbara
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

7.  [Vitreoretinal traction syndrome in multiple sclerosis].

Authors:  A Hochwarter; C Prainer; S Binder; U Stolba
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

Review 8.  A clinical approach to the diagnosis of retinal vasculitis.

Authors:  Ahmed M Abu El-Asrar; Carl P Herbort; Khalid F Tabbara
Journal:  Int Ophthalmol       Date:  2009-02-04       Impact factor: 2.031

9.  The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.

Authors:  Bernhard H J Juurlink
Journal:  Mult Scler Int       Date:  2013-04-04

10.  A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?

Authors:  Grant A Bateman; Jeannette Lechner-Scott; Rodney A Lea
Journal:  Fluids Barriers CNS       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.